Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation

Phase 4

Completed

• Conditions: Subfertility
• Interventions: Drug: Cetrorelix (Cetrotide)

• Registration Number: NCT01005784
• Lead Sponsor: Aristotle University Of Thessaloniki

Brief Summary

This is a comparison of pregnancy achievement between two GnRH antagonist protocols which differ in the timing of GnRH antagonist initiation.

Detailed Description

Not available

Study Timeline

• Study Start: 2005-06
• Study First Submitted: 2007-11-13
• Primary Completion: 2008-01
• Study Completion: 2008-03
• Status Verified: 2009-10
• Study First Submitted QC: 2009-10-30
• Last Update Submitted: 2009-10-30
• Study First Posted: 2009-11-01
• Last Update Posted: 2009-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 146

Inclusion Criteria

• < 39 years of age
• BMI 18.5-29.9
• <= 3 previous IVF cycles

Exclusion Criteria

• PCOS
• Endometriosis

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
flexible	Cetrorelix (Cetrotide)	-
fixed	Cetrorelix (Cetrotide)	-

Primary Outcome Measures

Name	Time	Method
Luteinizing hormone rise	3-14 days (duration of ovarian stimulation)

Trial Locations

Locations (1)

Unit for Human Reproduction; 🇬🇷 Thessaloniki, Greece